Literature DB >> 31463094

Contrast induced acute kidney injury and the role of beta-blockers in its prevention.

Umberto Barbero1, Mario Iannaccone1, Michele De Benedictis1, Baldassarre Doronzo1.   

Abstract

Entities:  

Year:  2019        PMID： 31463094      PMCID： PMC6687990          DOI： 10.21037/jtd.2019.06.53

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  51 in total

1.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

Authors:  H J Dargie
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

2.  Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction.

Authors:  Alexander Goldberg; Haim Hammerman; Sirouch Petcherski; Alexander Zdorovyak; Sergey Yalonetsky; Michael Kapeliovich; Yoram Agmon; Walter Markiewicz; Doron Aronson
Journal:  Am Heart J       Date:  2005-08       Impact factor: 4.749

3.  Iodinated contrast induced renal vasoconstriction is due in part to the downregulation of renal cortical and medullary nitric oxide synthesis.

Authors:  Stuart I Myers; Li Wang; Fang Liu; Lori L Bartula
Journal:  J Vasc Surg       Date:  2006-08       Impact factor: 4.268

4.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

Authors:  Giancarlo Marenzi; Gianfranco Lauri; Emilio Assanelli; Jeness Campodonico; Monica De Metrio; Ivana Marana; Marco Grazi; Fabrizio Veglia; Antonio L Bartorelli
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

Review 5.  Acute renal failure: much more than a kidney disease.

Authors:  K J Kelly
Journal:  Semin Nephrol       Date:  2006-03       Impact factor: 5.299

6.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.

Authors:  Beth A Bartholomew; Kishore J Harjai; Srinivas Dukkipati; Judith A Boura; Michael W Yerkey; Susan Glazier; Cindy L Grines; William W O'Neill
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

7.  Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.

Authors:  Hanke Mollnau; Eberhard Schulz; Andreas Daiber; Stephan Baldus; Matthias Oelze; Michael August; Maria Wendt; Ulrich Walter; Carolin Geiger; Rahul Agrawal; Andrei L Kleschyov; Thomas Meinertz; Thomas Münzel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-06       Impact factor: 8.311

8.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

9.  Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine.

Authors:  Joseph Lindsay; Sue Apple; Ellen E Pinnow; Natalie Gevorkian; Luis Gruberg; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; William Suddath; Ron Waksman
Journal:  Catheter Cardiovasc Interv       Date:  2003-07       Impact factor: 2.692

10.  The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure.

Authors:  Toshihide Fujii; Hayato Kurata; Masanori Takaoka; Tomoko Muraoka; Yoshihide Fujisawa; Takatomi Shokoji; Akira Nishiyama; Youichi Abe; Yasuo Matsumura
Journal:  Eur J Pharmacol       Date:  2003-11-28       Impact factor: 4.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.